LB Pharma's $285M IPO: Biotech's Back?

Update: 2025-09-11

Description

Biotech's Back? LB Pharmaceuticals defies market slump with $285M IPO, becoming the first major biotech IPO since February. Find out how this risky venture, focused on a novel schizophrenia drug, plans to navigate the volatile biotech landscape and what this means for the rebounding IPO market.

Hosted on Acast. See acast.com/privacy for more information.

Comments

In Channel

Inflation Nation: August's Price Surge

2025-09-1101:30

Oracle's AI Surge: Larry Ellison Briefly Tops Elon Musk

2025-09-1101:33

Inflation's August Surprise: Fed Rate Cut Incoming?

2025-09-1102:03

ECB Holds Steady: What's Next for Euro Rates?

2025-09-1101:51

China's AI Chip Challenge: Breaking US Tech Dependence

2025-09-1102:20

Crypto Bubble Trouble: Boom, Bust, or Both?

2025-09-1101:52

ECB Holds Steady: Eurozone Economy Shows Promise

2025-09-1101:28

Fed Rate Cut Incoming: How Far Will They Go?

2025-09-1102:05

ECB Holds Steady: Navigating Tariffs and Trade Tensions

2025-09-1101:32

Kroger's Sales Forecast Rises: A Sign of Retail Resilience?

2025-09-1101:25

OPEC's Oil Outlook: Demand, Growth, and Market Share

2025-09-1101:22

Vera Bradley's $4.7 Million Loss: What's Next?

2025-09-1101:36

Pension Changes Loom? New Minister's Vague Budget Hints

2025-09-1101:50

Kroger's Mixed Bag: Profit Soars, Revenue Softens

2025-09-1101:21

Adobe's AI Gamble: Can It Recover?

2025-09-1102:21

IRA Wipeout: Did Your Spouse Steal Your Retirement?

2025-09-1101:54

ECB Holds Steady: Rates Unchanged, Inflation Forecasts Shift

2025-09-1101:47

ECB Holds Steady: Interest Rates Unchanged

2025-09-1101:43

Inflation Watch, Oracle Soars, and Klarna's Wild Ride

2025-09-1101:31

Figure Technologies IPO: A Blockchain Lending Game Changer

2025-09-1101:40

00:00

LB Pharma's $285M IPO: Biotech's Back?

#box-pro-ellipsis-175759748532130{-webkit-line-clamp:2;}LB Pharma's $285M IPO: Biotech's Back?

LB Pharma's $285M IPO: Biotech's Back?

LB Pharma's $285M IPO: Biotech's Back?